Muyi Yang
The Key Laboratory Of Experimental Teratology
Jinan, 250012, China
Jinan, 250012, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
SOX4 is activated by C-MYC in prostate cancer.
Journal: Medical oncology (Northwood, London, England)
Published: July 26, 2019
The Role of MicroRNAs in the Chemoresistance of Breast Cancer.
Journal: Drug development research
Published: August 28, 2015
Cul4B is a novel prognostic marker in cholangiocarcinoma.
Journal: Oncology letters
Published: July 26, 2015
Metformin inhibits epithelial-mesenchymal transition in prostate cancer cells: involvement of the tumor suppressor miR30a and its target gene SOX4.
Journal: Biochemical and biophysical research communications
Published: August 25, 2014
SOX4 is associated with poor prognosis in cholangiocarcinoma.
Journal: Biochemical and biophysical research communications
Published: August 19, 2014
Characterization of EGFR family gene aberrations in cholangiocarcinoma.
Journal: Oncology reports
Published: February 07, 2014
ERG-SOX4 interaction promotes epithelial-mesenchymal transition in prostate cancer cells.
Journal: The Prostate
Published: September 18, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026